Arrowhead Pharmaceuticals (ARWR) reported a fiscal Q1 net loss late Monday of $1.39 per diluted share, wider than a $1.24 loss a year earlier.
Analysts polled by FactSet expected a loss of $0.41.
Revenue for the quarter ended Dec. 31 was $2.5 million, compared with $3.6 million a year earlier.
Analysts polled by FactSet expected $72.8 million.
Shares of the company fell 1.9% in recent after-hours activity.
Price: 19.55, Change: -0.37, Percent Change: -1.86
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。